Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Induced by Repeated Forced Swimming in Mice.
Ohba, Takuya, Domoto, Shinichi, Tanaka, Miyu et al. · Biological & pharmaceutical bulletin · 2019 · DOI
Quick Summary
Researchers created a mouse model of ME/CFS by repeatedly forcing mice to swim, which produced fatigue-like behaviors similar to the human condition. They found that this stress reduced the activity of an important energy-producing enzyme called PDH in muscle cells. When they treated the mice with a drug that reactivates PDH, the fatigue-like symptoms improved, suggesting this enzyme may be a target for future ME/CFS treatments.
Why It Matters
This study provides experimental support for a specific metabolic mechanism—impaired PDH function—that may underlie ME/CFS fatigue, opening a potential new avenue for drug development. If PDH dysfunction is confirmed in human ME/CFS patients, it could justify clinical trials of PDH-activating drugs like DCA, offering hope for a targeted treatment approach for a condition that currently lacks effective therapies.
Observed Findings
Mice subjected to repeated forced swimming showed increased immobility time and delayed grooming onset in a time-dependent manner.
Swimming-stressed mice demonstrated decreased locomotor activity in the open field test compared to controls.
PDH enzyme activity was significantly reduced in mitochondria isolated from gastrocnemius muscle of stressed mice after 25 days.
Sodium dichloroacetate (DCA) treatment appeared to reduce fatigue-like behaviors in the ME/CFS mouse model.
Inferred Conclusions
A mouse model of ME/CFS-like fatigue can be successfully established using repeated forced swimming stress.
Decreased mitochondrial PDH activity is associated with fatigue-like symptoms in this stress model.
PDH activation via DCA may have therapeutic potential for mitigating fatigue in ME/CFS.
Remaining Questions
Does PDH dysfunction occur in human ME/CFS patients, and if so, is it a primary cause or a secondary consequence of the disease?
Would DCA or other PDH activators be safe and effective in clinical trials with ME/CFS patients?
Are there other mitochondrial dysfunctions occurring alongside PDH impairment that contribute to ME/CFS symptoms?
What This Study Does Not Prove
This study does not prove that PDH dysfunction causes ME/CFS in humans or that it is the primary mechanism of the disease. The forced swimming model induces acute stress-related fatigue in mice, which may differ mechanistically from human ME/CFS, which is often triggered by viral infection or other factors. The correlation between reduced PDH activity and fatigue-like behavior does not establish causation, and further research is needed to determine whether PDH activation would benefit human patients.
Tags
Symptom:PainFatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory Only
How does the metabolic dysfunction induced by forced swimming stress compare mechanistically to ME/CFS triggered by viral infection or other natural causes?